Search

everythinglearnresearchcommunity

for

Search:↓

A user shared their hair regrowth journey, using a treatment protocol that includes 1mg finasteride daily, 1ml minoxidil twice daily, 1.5mm microneedling weekly, oral castor oil, and ketoconazole shampoo. They also improved their diet, hydration, and took supplements, and have seen positive results after 3.5 months.

The conversation discusses the potential availability of a new hair loss treatment, GT20029, on the grey market, with users suggesting it could be within a year but advising against using grey market products due to safety concerns and complexity of the drug.

The user shared their 18-month hair loss treatment progress, using finasteride three times a week, daily minoxidil, weekly vitamin D, and bi-weekly nizoral shampoo. They experienced initial shedding and greying, but are satisfied with the results.

EDHARRINGTON's journey to regrow his hair using finasteride, topical minoxidil, and micro-needling treatments over 4 years, with others commenting their support and admiration for his results.

A 42-year-old had 2,100 grafts transplanted to the frontal third of the scalp, using treatments like Dutasteride, oral Minoxidil, ketoconazole shampoo, dermarolling, and PRP. They plan to add RU58841 and have scheduled SMP to improve cosmetic results.

The conversation discusses alternatives to 5AR inhibitors for hair loss treatment, suggesting options like minoxidil, KX-826, pyrilutimide, microneedling, and topical bicalutamide. Concerns about side effects and the effectiveness of these treatments are also highlighted.

People are discussing the potential of a new hair loss treatment, pp405, and its approval timeline, comparing it to existing treatments like Minoxidil and finasteride. There is skepticism about its effectiveness and concerns about the time it will take for approval and availability, especially in Europe.

A male in his thirties with a Norwood 2 hairline questions if gym gains and supplements like creatine cause hair loss. Responses suggest that while exercise can slightly increase testosterone and DHT, genetics primarily determine hair loss, and treatments like finasteride are recommended for DHT control.

Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

The conversation is about a person recovering from drug-induced malnourishment, regaining hair growth, and improving overall health. They attribute their progress to stopping drug use, focusing on nutrition, and possibly using hormone replacement therapy (HRT).